Saudi Pharmaceutical Industries and Medical Appliances Corp 2022 AR2
The report outlines SPIMACO's strategic and financial performance for the fiscal year 2022, highlighting its ongoing transformation to become a national pharmaceutical champion in Saudi Arabia and the MENA region. Key achievements during the year included the inauguration of KSA's first-of-its-kind oncology and high-potent drugs facility in Qassim and the relaunch of the CAD active pharmaceutical ingredients facility. Despite global supply chain disruptions and inflationary pressures, the company achieved an 18% increase in production output, exceeding 1.6 billion units. Financially, the group reported revenues of SAR 1.43 billion, representing a slight year-on-year decline, and a net loss of SAR 171.2 million due to strategic turnaround investments.
Company: Saudi Pharmaceutical Industries and Medical Appliances Corp
Sector: Manufacturing
Country: Saudi Arabia
Year: 2022
Type: AR2
Pages: 91
Back to company
Saudi Pharmaceutical Industries and Medical Appliances Corp
Annual Report
The report outlines SPIMACO's strategic and financial performance for the fiscal year 2022, highlighting its ongoing transformation to become a national pharmaceutical champion in Saudi Arabia and the MENA region. Key achievements during the year included the inauguration of KSA's first-of-its-kind oncology and high-potent drugs facility in Qassim and the relaunch of the CAD active pharmaceutical ingredients facility. Despite global supply chain disruptions and inflationary pressures, the company achieved an 18% increase in production output, exceeding 1.6 billion units. Financially, the group reported revenues of SAR 1.43 billion, representing a slight year-on-year decline, and a net loss of SAR 171.2 million due to strategic turnaround investments.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees